Over half a million people die from cancer every year, according to current statistics. For those diagnosed with pancreatic cancer, the current five-year …
UTHSC
UTRF Celebrates Record Number of Licenses, Agreements, Patents at Annual Innovation Awards
This spring, the University of Tennessee Research Foundation was honored to recognize UT innovators from across the state at UTRF’s annual Innovation Awards. …
UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA
UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized …